Chubbuck, IDNCT04557462Now EnrollingIRB Ready

IgA Nephropathy Clinical Trial in Chubbuck, ID

Access cutting-edge iga nephropathy treatment through this clinical trial at a research site in Chubbuck. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Chubbuck location

Preparing your pre-screening questions...

Expert Care in Chubbuck

Access iga nephropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related iga nephropathy treatment provided free

Apply for This Chubbuck Location

Check if you qualify for this iga nephropathy clinical trial in Chubbuck, ID

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chubbuck

    Convenient for ID residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chubbuck site if eligible
  4. 4Begin participation

About This IgA Nephropathy Study in Chubbuck

The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who have completed either the CLNP023X2203 or CLNP023A2301 clinical trials. The open-label design of the current study is appropriate to provide study participants the opportunity to receive treatment with iptacopan until marketing authorizations are received and the drug product becomes commercially available while enabling collection of long-term safet

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

For LNP023X2203, participants must have completed part 1 or part 2 of the trial. For LNP023A2301, participants must have completed the entire core trial defined as the full 24 month treatment period.
≥ 20 ml/min/1.73m2 \*eGFR calculated using the CKD-EPI formula (or modified MDRD formula according to specific ethnic groups and local practice guidelines)
Per investigator's clinical judgement, the participant may benefit from receiving the open-label treatment of iptacopan 200 mg b.i.d.
Prior Vaccination against Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae infections should be up to date (i.e. any boosters required administered according to local regulations.
All participants must be on supportive care regimen of ACEi or ARB\
as per KDIGO guidelines.
participants who are not taking KDIGO guideline doses because they have documented allergies or intolerance to ACEi and ARB are eligible for the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chubbuck?

Yes, this clinical trial (NCT04557462) has an active research site in Chubbuck, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

IgA Nephropathy Treatment Options in Chubbuck, ID

If you're searching for iga nephropathy treatment options in Chubbuck, ID, this clinical trial (NCT04557462) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chubbuck research site is actively enrolling participants for this clinical trial. You'll receive care from experienced iga nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all iga nephropathy clinical trials near you to find additional studies recruiting in your area.

More IgA Nephropathy Trials in Chubbuck, ID

See all iga nephropathy clinical trials recruiting in Chubbuck — not just this study.

Browse IgA Nephropathy Trials in Chubbuck

Ready to Join in Chubbuck?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chubbuck, ID